Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 03 Feb 2022 for Spero Therapeutics, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
David A. Melnick: trading record in brief
All filings by David A. Melnick on record concern Spero Therapeutics, Inc., in the capacity of senior executive. We count 2 filings; the first trade dates from 26 August 2021 and the latest from 1 February 2022.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 3 February 2022, reports a share grant in Spero Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to David A. Melnick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
38,014 shares0Common StockSEC:0000899243-22-004594:0
24,067 shares0Common StockSEC:0000899243-21-034503:0
2 of 2 declarations
